Can video chats ease stress for breast cancer survivors?
NCT ID NCT06924788
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a 10-week video-based stress management program (VSMART) is practical and helpful for 25 breast cancer survivors in Alabama. Participants join group discussions from home. The goal is to see if the program improves wellbeing and to gather feedback from survivors and healthcare providers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Video-conferenced stress management and relaxation training (VSMART)
- What this could lead to
- If successful, this could provide a practical, home-based stress management option for breast cancer survivors in underserved areas.
- What could go wrong
- This is a small, early feasibility study with only 25 participants, so results may not apply broadly. The program may not show clear benefits or be difficult to implement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Exercise during chemo: a new weapon to preserve strength?
- Could a smartphone program ease Chemo's emotional toll?
- Could fewer heart tests be safer for breast cancer patients?
- New study aims to predict who will respond to breast cancer therapy
- Blood test could revolutionize breast cancer monitoring
- Tech trio aims to help breast cancer survivors remember daily pills